netagen

contains 4 mg 17 beta-estradiol & 3 mg norethindrone acetate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Weight Gain 09/01/1979 - "The numbers discontinuing treatment were about the same in the three groups, the main reasons being intermenstrual spotting in those on Netagen 423, amenorrhoea and weight gain in those on Netagen 403 and nausea and weight gain in those on Netasyn. "
2.	Nausea 09/01/1979 - "The numbers discontinuing treatment were about the same in the three groups, the main reasons being intermenstrual spotting in those on Netagen 423, amenorrhoea and weight gain in those on Netagen 403 and nausea and weight gain in those on Netasyn. "
3.	Metrorrhagia (Spotting) 09/01/1979 - "The numbers discontinuing treatment were about the same in the three groups, the main reasons being intermenstrual spotting in those on Netagen 423, amenorrhoea and weight gain in those on Netagen 403 and nausea and weight gain in those on Netasyn. "

1.	ferrous fumarate drug combination ethinyl estradiol norethindrone acetate (Zoran)